custom image

Genomic Stability and DNA Repair

September 21-23, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change


This virtual conference seeks to connect emerging mechanisms of DNA repair and replication with genome stability. The significance and complexity of the DNA damage response cannot be understated, with a central role in reproduction, development, and genome evolution, as highlighted by the many human disease states that occur from genome instability stemming from DNA repair deficiency. The scientific program reflects the importance of classical processes such as DNA replication and homology directed DNA repair in genome integrity, while highlighting emerging aspects of the DNA damage response involving noncoding RNA, chromatin recognition and organization, and catastrophic rearrangements that emanate from mitosis. An additional area of innovation is the realization that genome stability influences human physiology through its signaling to metabolism, the immune system, hematopoietic stem cells, and developmental biology. We will emphasize the importance of fundamental DNA repair mechanisms to organismal biology in normal and pathophysiological states, including opportunities to exploit the DNA damage response for therapeutic gain and genome engineering. The scientific program encompasses two keynote speakers, eight plenary sessions and four workshops, that collectively, represent the most exciting aspects of the field and bring together a scientifically diverse group of international investigators to promulgate interdisciplinary areas of exploration.

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Pricing:

Registration for this meeting is now closed.

Deadlines:

Scholarships: Passed
Abstract Submission: Passed

#VKSDNArepair21




Program Details




Speaking at this eSymposia


Mirit Aladjem

NCI, National Institutes of Health, USA


Simon J. Boulton

Francis Crick Institute, UK


J. Ross Chapman

University of Oxford, UK


Irene Chiolo

University of Southern California, USA


Dipanjan Chowdhury

Dana-Farber Cancer Institute, Harvard Medical School, USA


Karlene A. Cimprich

Stanford University, USA


David Cortez

Vanderbilt University School of Medicine, USA


Alan D. D'Andrea

Dana-Farber Cancer Institute, USA


Titia de Lange

Rockefeller University, USA


Daniel Durocher

Lunenfeld-Tanenbaum Research Institute, Canada


Anindya Dutta

University of Virginia, USA


Roger Greenberg

University of Pennsylvania, USA


Jacqueline J. Jacobs

Netherlands Cancer Institute, Netherlands


Maria Jasin

Memorial Sloan Kettering Cancer Center, USA


Gaelle Legube

Center for Integrative Biology, France


Joachim Lingner

École Polytechnique Fédérale de Lausanne, Switzerland


Nima Mosammaparast

Washington University in St. Louis, USA


André Nussenzweig

NCI, National Institutes of Health, USA


David Pellman

Dana-Farber Cancer Institute, USA


Katharina Schlacher

MD Anderson Cancer Center, USA


Barry P. Sleckman

University of Alabama Birmingham School of Medicine, USA


Patrick M. Sung

University of Texas Health Science Center at San Antonio, USA


Lorraine S. Symington

Columbia University, USA


Madalena Tarsounas

University of Oxford, UK


Helle D. Ulrich

Institute of Molecular Biology, Germany


Lee Zou

Harvard Medical School, USA





Sponsors



 

custom image

 




Additional Support



sponsor-carousel-ASGCT.png

custom image

sponsor-carousel-lumicks.png

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation




Media In-Kind Sponsors



EMBO

JEM and JCB

Frontiers

custom image





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Donate to Keystone Symposia


custom image